Clinical Trial Update: Identification of Allergen-reactive Antibodies in the Blood of Pollen Allergic Patients

View source ↗

Summary

Mabylon AG reports a clinical trial enrolling participants to identify allergen-reactive antibodies in the blood of patients with pollen allergy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pollen Allergy

Snippet

Sponsor: Mabylon AG | Conditions: Pollen Allergy | Status: ENROLLING_BY_INVITATION